Study Points To New Treatment For Steroid-Induced Osteoporosis
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




Study Points To New Treatment For Steroid-Induced Osteoporosis

IOWA CITY, IA -- November 17, 1997 -- A University of Iowa (UI) rheumatologist reports Fosamax (Fosamax) may help prevent steroid-induced osteoporosis, the second most common cause of osteoporosis in post-menopausal women.

Dr. Kenneth Saag, UI assistant professor of internal medicine, presented his findings yesterday at the American College of Rheumatology National Scientific Meeting in Washington, MD. UI researchers and investigators at Le Centre Hospitalier at the Universite de Quebec, studied 560 steroid therapy patients over 48 weeks who were undergoing steroid therapy. The patients received either an oral dose of Fosamax or an inactive placebo. All the patients also were given calcium and vitamin D supplements.

"Steroids are often prescribed by doctors for a number of medical conditions, including rheumatoid arthritis, asthma and inflammatory bowel disease," Saag said. "While steroids are effective in treating these diseases, osteoporosis is often a serious side effect."

Saag and his colleagues found that Fosamax significantly increased bone mass at the spine and hip in men and women taking steroids compared to placebo. The UI and Canadian studies also showed fewer patients on Fosamax had spine fractures compared to those patients of placebo. In addition, Fosamax reduced spine fractures by more than 65 percent in post-menopausal women on corticosteroid therapy.

Researchers already knew Fosamax could help treat general osteoporosis, Saag explained, but the new findings show that the drug can also play a role in preventing and treating osteoporosis caused by steroids.

"As many as 30 million Americans are affected by diseases that may require corticosteroid use," he said. "Calcium and vitamin D supplements, hormone replacement therapy and exercise are the recommended modes of therapy, but our study shows that this particular medication may have a significant impact, as well."

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities